Retatrutide is the experimental drug currently being developed by the pharmaceutical company Eli Lily that is being considered for the treatment of obesity and type 2 diabetes. It belongs to a class of drugs known as triple hormone receptor agonists. Trials involving this treatment indicates its effectiveness, with some experts highlighting its potential as a next generation weight loss medication.
It works by acting as a triple hormone receptor agonist. By activating the hormones that control metabolism, blood sugar and appetite, retatrutide help breakdown stored fats at the same time as reducing appetite. The triple action effect of this treatment sets it apart from previous generations of weight loss medication.
This treatment is administered via an injection using a retatrutide pen style injector. The injection should be done into the stomach, upper arm or thigh. It is expected to become available in a number of vial sizes including 20mg, 40mg and 60mg. This medication should only be taken after direct consultation with a GP or licensed medical professional.
Although results in clinical trials varied between patients, a reduction in appetite is usually noticed during the first two weeks of treatment. This is followed by weight loss within the first 28 days. Although it is still undetermined how long this mediation can be taken, studies conducted over 48 - 68 weeks showed this treatments, continued effectiveness throughout.
Yes, during clinical trials this medication has shown outstanding results for burning fat. By reducing how much people eat at the same time as targeting stored fats, weight loss can be considerable. Burning stored fat is the key to sustained weight loss. Eating healthy fats is another great way, as it helps trains the body to burn fat as fuel.
It targets the GLP-1, GIP, and GCG receptors responsible for appetite, metabolism and blood sugar. GLP-1 reduces hunger, slows digestion and makes people feel like they have already eaten. GIP modifies blood sugar levels and GCG works by increasing the amount of energy spent and speeds up the breaking down of fats.
No, this experimental medication is not a steroid. It is a peptide based drug that is being developed specifically as a weight loss medication. Peptides and steroids are two different classes of compounds, where peptides act as a natural messenger that encourages the body to perform at its optimum, steroids are a synthetic hormone that put the body into overdrive to force results. Peptides are seen as a safer and more sustainable approach to weight loss.
During clinical trials, no evidence has been found to suggest that this treatment causes hair loss. The event of hair loss during treatment is usually a result of nutrient deficiencies caused by the sudden loss of weight. In the event of hair loss during treatment it is important to speak to the consulting doctor.
It is important to store unopened retatrutide in the refrigerator before planned use. Once opened, it can stay at room temperature for up to 3 weeks or 21 days. It is recommended to follow the specific instructions that accompanies the medication and keep out of the reach of children and pets.
Although early signs are promising, this medication is not yet regarded as safe. This is due to its experimental status and the fact that research is ongoing and regulatory approval has not yet been confirmed. People considering this treatment must only do so after approval from a Doctor or qualified medical professional. Taking this treatment before its approval comes with extreme risks and should be avoided.
Yes, during clinical trials side effects such as nausea, diahorrea, vomiting, constipation, fatigue, abdominal pain and headaches have been experienced in anywhere from 16% - 63% of trial participants. Less commonly experienced side effects include but are not limited to skin sensitivity, increased heart rate, pancreatitis, increase in liver enzymes and gallbladder issues. These affected in the region of 1% to 7% of trial participants.
Although research is still ongoing, clinical trials have highlighted a number of patient groups who should not take this medication. This includes but is not limited to people with cancer, pancreas issues, gastrointestinal disease, adolescents or children, people with endocrine disorder, severe liver or kidney disease and people using other weight loss drugs. As it is not yet approved, people should only take this experimental drug if approved by a medical professional.
Although retatrutide has not yet been approved by the FDA, it is currently in phase 3 of the clinical trials which are expected to be concluded early in 2026 with FDA approval expected later in 2026.
No, this medication is not yet approved in the UK. It is important for people considering this treatment to speak to their healthcare provider about suitable treatment options.
The availability of this treatment in the UK will only be considered after phase 3 clinical trials have been concluded. With phase 3 trials expected to conclude in 2026, it is expected to be approved in the UK sometime in 2027.
This medication is still in late stage clinical trials and is not yet available for sale in the UK. Although some online pharmacies may have this medication on offer for experimental use, it is important for people considering the treatment to discuss its use with their Doctor beforehand.
It is important for people considering accessing medication online to check that the pharmacy in question is genuine. This can be done by checking that the pharmacy is registered with the GPhC in the UK.
As this treatment is not yet on sale in the UK it is hard to give an exact price. Once it is approved in the UK, treatment is expected to range from £150 - £350 per month.
Yes, all information remains private and is protected with cutting edge technology. From the moment clients enter the digital store, through payment to delivery, measures are in place to protect patient privacy and maintain client confidence.
Yes, this website uses the latest SSL encryption to secure client data. Websites that have HTTPS instead of HTTP are secure. Avoid using websites without the 'S ' as these websites do not provide a secure channel between devices and are prone to security breaches.
To ensure patient privacy there will be no mention of retatrutide, the website name or the fact that this is an experimental treatment on any billing information. Once the transaction is confirmed an email will be sent confirming the unconnected name on bank statement and billing information.
Yes, patients that qualify for this treatment experimentally can get it delivered. Online pharmacies remove the need for collecting medication in person and offer a fast and discreet home delivery service. Packages are packed to ensure non-disclosure of the contents and maintain patient privacy.
Yes, to ensure clients stay informed we email the tracking details assigned to the order once the shipment has been processed for dispatch. Please ensure the correct email id and contact details are entered during checkout. UK orders will typically arrive to towns and cities in as little as 2 days. Remote locations or deliveries outside of the UK can take 4-7 working days.
In the unlikely event that a parcel doesn't arrive or arrives incomplete, it is the responsibility of the customers to report it to us within 7 days of delivery or the estimated delivery date emailed on dispatch. The claim will then be forwarded to our dispatch department for further investigation and a replacement order sent, if approved. In the event the parcel is incomplete, customers should provide photographic evidence of the parcel, tracking number and contents.
Yes, we believe in the importance of great communication. To ensure our clients can get real time answers to any inquiries, our professionally trained team are on hand 24/7. Getting in touch is easy. The first option is to send us an email, all inquiries sent via email are replied to within 24 hours. Urgent inquiries should be directed to our customer hotline or live chat feature. Here patients can get answers in real time throughout the course of the day.
Absolutely, we encourage all our clients to rate our service and leave a review. As this is an experimental drug, it is important for people to have as much information as possible about it. By sharing their experiences, through reviews, our clients can play an important role in highlighting any potential risks or benefits of this treatment.
